Raffles Medical Group Ltd

BSL.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BSL.SI stands at 1.93B. In comparison, Q0F.SI has a market cap of 18.52B. Regarding current trading prices, BSL.SI is priced at $1.04, while Q0F.SI trades at $2.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BSL.SI currently has a P/E ratio of 34.67, whereas Q0F.SI's P/E ratio is 23.33. In terms of profitability, BSL.SI's ROE is +0.04%, compared to Q0F.SI's ROE of N/A. Regarding short-term risk, BSL.SI is more volatile compared to Q0F.SI. This indicates potentially higher risk in terms of short-term price fluctuations for BSL.SI.

BSL.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BSL.SI stands at 1.93B. In comparison, QC7.SI has a market cap of 303.66M. Regarding current trading prices, BSL.SI is priced at $1.04, while QC7.SI trades at $0.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BSL.SI currently has a P/E ratio of 34.67, whereas QC7.SI's P/E ratio is 16.00. In terms of profitability, BSL.SI's ROE is +0.04%, compared to QC7.SI's ROE of +0.14%. Regarding short-term risk, BSL.SI is less volatile compared to QC7.SI. This indicates potentially lower risk in terms of short-term price fluctuations for BSL.SI.

BSL.SI plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BSL.SI stands at 1.93B. In comparison, 9G2.SI has a market cap of 32.92M. Regarding current trading prices, BSL.SI is priced at $1.04, while 9G2.SI trades at $0.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BSL.SI currently has a P/E ratio of 34.67, whereas 9G2.SI's P/E ratio is -1.03. In terms of profitability, BSL.SI's ROE is +0.04%, compared to 9G2.SI's ROE of -0.38%. Regarding short-term risk, BSL.SI is less volatile compared to 9G2.SI. This indicates potentially lower risk in terms of short-term price fluctuations for BSL.SI.